Dear all STI has been on a tear since the start of the year. With reference to my write-up published on 5 Jan 2022 (click HERE) citing that Asian indices are likely to outperform that of the U.S. market in 2022, STI has indeed notched strong year to date (“YTD”) gains of 10.1% to close 3,439 on 16 Feb 2022. This outperformance is especially stark if we compare it to S&P500’s -6.1% YTD returns. As I have shared with Lianhe Zaobao on 9 Feb 2022, I personally feel that our STI is overbought in the near term with several near-term headwinds. Let’s take a look at my basis below. This post was originally posted here. Ernest Lim provide readers with in-depth insights into SGX listed companies. His writings have been featured in various mainstream & online media. Holding both a CFA® charter and CA Singapore designation, Ernest is an avid investor, trader &...